FDA Commissioner Scott Walker has been very public in expressing his desire to provide increased competition and greater protection to American consumers in a bid to drive down prices of prescription medicines . The FDA has indicated a willingness to grant broader approvals in orphan diseases, but this decision was uncommon in that U.S. health regulators had already approved another drug, Tesaro’s niraparib Recently , the agency he oversees took some unusual steps to back up those views with action .
FDA Commissioner Scott Walker has been very public in expressing his desire to provide increased competition and greater protection to American consumers in a bid to drive down prices of prescription medicines . Recently , the agency he oversees took some unusual steps to back up those views with action .